A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 25, 2020 Category: Cancer & Oncology Source Type: clinical trials

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 25, 2020 Category: Cancer & Oncology Source Type: clinical trials

Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 25, 2020 Category: Cancer & Oncology Source Type: clinical trials

The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 25, 2020 Category: Cancer & Oncology Source Type: clinical trials

A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 25, 2020 Category: Cancer & Oncology Source Type: clinical trials

Northwell neurosurgeon first on Long Island to use Modus V ™ 3D exoscope to remove brain tumor
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

Ketone-Supressing Drug Combats Rare Brain Cancer in Mice
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 (Gliovac) in Recurrent Glioblastoma Patients
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

Northwell neurosurgeon first on Long Island to use Modus V ™ 3D exoscope to remove brain tumor
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

Ketone-Supressing Drug Combats Rare Brain Cancer in Mice
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 (Gliovac) in Recurrent Glioblastoma Patients
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

Northwell neurosurgeon first on Long Island to use Modus V ™ 3D exoscope to remove brain tumor
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

Ketone-Supressing Drug Combats Rare Brain Cancer in Mice
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 (Gliovac) in Recurrent Glioblastoma Patients
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials

Northwell neurosurgeon first on Long Island to use Modus V ™ 3D exoscope to remove brain tumor
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - August 24, 2020 Category: Cancer & Oncology Source Type: clinical trials